vs
Side-by-side financial comparison of Solventum (SOLV) and V F CORP (VFC). Click either name above to swap in a different company.
V F CORP is the larger business by last-quarter revenue ($2.9B vs $2.0B, roughly 1.4× Solventum). V F CORP runs the higher net margin — 10.5% vs 0.6%, a 9.8% gap on every dollar of revenue. On growth, V F CORP posted the faster year-over-year revenue change (1.5% vs -3.0%). V F CORP produced more free cash flow last quarter ($977.9M vs $-273.0M). Over the past eight quarters, V F CORP's revenue compounded faster (10.1% CAGR vs -1.8%).
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
The F. W. Woolworth Company was a retail company and one of the pioneers of the five-and-dime store. It was among the most successful American and international five-and-dime businesses, setting trends and creating the modern retail model that stores worldwide follow today.
SOLV vs VFC — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $2.9B |
| Net Profit | $13.0M | $300.8M |
| Gross Margin | 54.7% | 56.6% |
| Operating Margin | 4.0% | 10.1% |
| Net Margin | 0.6% | 10.5% |
| Revenue YoY | -3.0% | 1.5% |
| Net Profit YoY | — | 79.3% |
| EPS (diluted) | $0.07 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.9B | ||
| Q3 25 | $2.1B | $2.8B | ||
| Q2 25 | $2.2B | $1.8B | ||
| Q1 25 | $2.1B | $2.0B | ||
| Q4 24 | $2.1B | $2.8B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.1B | $1.9B |
| Q1 26 | $13.0M | — | ||
| Q4 25 | $63.0M | $300.8M | ||
| Q3 25 | $1.3B | $189.8M | ||
| Q2 25 | $90.0M | $-116.4M | ||
| Q1 25 | $137.0M | $-150.8M | ||
| Q4 24 | $31.0M | $167.8M | ||
| Q3 24 | $122.0M | $52.2M | ||
| Q2 24 | $89.0M | $-258.9M |
| Q1 26 | 54.7% | — | ||
| Q4 25 | 51.4% | 56.6% | ||
| Q3 25 | 54.2% | 52.2% | ||
| Q2 25 | 54.4% | 53.9% | ||
| Q1 25 | 53.8% | 52.7% | ||
| Q4 24 | 53.9% | 56.3% | ||
| Q3 24 | 56.0% | 52.2% | ||
| Q2 24 | 54.6% | 52.0% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 6.3% | 10.1% | ||
| Q3 25 | 80.6% | 11.2% | ||
| Q2 25 | 9.9% | -4.9% | ||
| Q1 25 | 7.3% | 2.2% | ||
| Q4 24 | 6.6% | 8.0% | ||
| Q3 24 | 13.2% | 9.9% | ||
| Q2 24 | 11.7% | -12.6% |
| Q1 26 | 0.6% | — | ||
| Q4 25 | 3.2% | 10.5% | ||
| Q3 25 | 60.4% | 6.8% | ||
| Q2 25 | 4.2% | -6.6% | ||
| Q1 25 | 6.6% | -7.5% | ||
| Q4 24 | 1.5% | 5.9% | ||
| Q3 24 | 5.9% | 1.9% | ||
| Q2 24 | 4.3% | -13.6% |
| Q1 26 | $0.07 | — | ||
| Q4 25 | $0.37 | $0.76 | ||
| Q3 25 | $7.22 | $0.48 | ||
| Q2 25 | $0.51 | $-0.30 | ||
| Q1 25 | $0.78 | $-0.37 | ||
| Q4 24 | $0.18 | $0.43 | ||
| Q3 24 | $0.70 | $0.13 | ||
| Q2 24 | $0.51 | $-0.67 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $561.0M | $1.5B |
| Total DebtLower is stronger | $4.6B | $3.6B |
| Stockholders' EquityBook value | $5.0B | $1.8B |
| Total Assets | $14.1B | $10.4B |
| Debt / EquityLower = less leverage | 0.92× | 1.99× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $561.0M | — | ||
| Q4 25 | $878.0M | $1.5B | ||
| Q3 25 | $1.6B | $419.1M | ||
| Q2 25 | $492.0M | $642.4M | ||
| Q1 25 | $534.0M | $429.4M | ||
| Q4 24 | $762.0M | $1.4B | ||
| Q3 24 | $772.0M | $492.2M | ||
| Q2 24 | $897.0M | $637.4M |
| Q1 26 | $4.6B | — | ||
| Q4 25 | $5.0B | $3.6B | ||
| Q3 25 | $5.1B | $3.5B | ||
| Q2 25 | $7.8B | $3.6B | ||
| Q1 25 | $7.9B | $3.4B | ||
| Q4 24 | $8.0B | $3.9B | ||
| Q3 24 | $8.1B | $4.0B | ||
| Q2 24 | $8.3B | $3.9B |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $1.8B | ||
| Q3 25 | $5.0B | $1.5B | ||
| Q2 25 | $3.6B | $1.3B | ||
| Q1 25 | $3.3B | $1.5B | ||
| Q4 24 | $3.0B | $1.7B | ||
| Q3 24 | $3.2B | $1.4B | ||
| Q2 24 | $2.9B | $1.4B |
| Q1 26 | $14.1B | — | ||
| Q4 25 | $14.3B | $10.4B | ||
| Q3 25 | $14.0B | $10.6B | ||
| Q2 25 | $15.1B | $10.2B | ||
| Q1 25 | $14.5B | $9.4B | ||
| Q4 24 | $14.5B | $10.6B | ||
| Q3 24 | $14.7B | $12.2B | ||
| Q2 24 | $14.6B | $11.5B |
| Q1 26 | 0.92× | — | ||
| Q4 25 | 1.00× | 1.99× | ||
| Q3 25 | 1.03× | 2.40× | ||
| Q2 25 | 2.14× | 2.76× | ||
| Q1 25 | 2.43× | 2.30× | ||
| Q4 24 | 2.71× | 2.31× | ||
| Q3 24 | 2.54× | 2.86× | ||
| Q2 24 | 2.90× | 2.84× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.0B |
| Free Cash FlowOCF − Capex | $-273.0M | $977.9M |
| FCF MarginFCF / Revenue | -13.6% | 34.0% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | — | 3.36× |
| TTM Free Cash FlowTrailing 4 quarters | $-203.0M | $357.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $95.0M | $1.0B | ||
| Q3 25 | $76.0M | $-227.0M | ||
| Q2 25 | $169.0M | $-145.5M | ||
| Q1 25 | $29.0M | $-171.1M | ||
| Q4 24 | $219.0M | $918.1M | ||
| Q3 24 | $169.0M | $-301.6M | ||
| Q2 24 | $355.0M | $19.8M |
| Q1 26 | $-273.0M | — | ||
| Q4 25 | $32.0M | $977.9M | ||
| Q3 25 | $-21.0M | $-253.5M | ||
| Q2 25 | $59.0M | $-173.7M | ||
| Q1 25 | $-80.0M | $-193.0M | ||
| Q4 24 | $92.0M | $899.7M | ||
| Q3 24 | $76.0M | $-322.4M | ||
| Q2 24 | $297.0M | $-5.4M |
| Q1 26 | -13.6% | — | ||
| Q4 25 | 1.6% | 34.0% | ||
| Q3 25 | -1.0% | -9.0% | ||
| Q2 25 | 2.7% | -9.9% | ||
| Q1 25 | -3.9% | -9.6% | ||
| Q4 24 | 4.4% | 31.7% | ||
| Q3 24 | 3.7% | -11.7% | ||
| Q2 24 | 14.3% | -0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 1.1% | ||
| Q3 25 | 4.6% | 0.9% | ||
| Q2 25 | 5.1% | 1.6% | ||
| Q1 25 | 5.3% | 1.1% | ||
| Q4 24 | 6.1% | 0.6% | ||
| Q3 24 | 4.5% | 0.8% | ||
| Q2 24 | 2.8% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | 3.36× | ||
| Q3 25 | 0.06× | -1.20× | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 7.06× | 5.47× | ||
| Q3 24 | 1.39× | -5.78× | ||
| Q2 24 | 3.99× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SOLV
| Infection Prevention and Surgical Solutions | $737.0M | 37% |
| Advanced Wound Care | $497.0M | 25% |
| Dental Solutions | $354.0M | 18% |
| Health Information Systems | $342.0M | 17% |
| All Other 4 | $76.0M | 4% |
VFC
| Outdoor | $1.9B | 67% |
| Sales Channel Through Intermediary | $813.4M | 28% |
| Other | $136.3M | 5% |
